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A primary goal of gut-brain research is to understand how human gut microbiota affect mental health 
such as cognition or neuropsychiatric disorders. Studies employing rodent models reported that gut 
microbiota had a strong influence on neurodevelopment, especially during the critical period of 
‘developmental programming’, which seems to be a key window for external influences. However, 
knowledge of the origins of the relationship between gut-microbiota and brain functions is still limited 
due to the scarcity of the human gut-brain studies, particularly those focusing on infant populations. 
Deep brain structures, in particular subcortical structures such as the striatum, are major components 
to the gut-brain axis and also have been shown to have a central role in neurodevelopment. Finally, 
previous literature demonstrates that the first years of life are critical to neurodevelopment and 
gastrointestinal colonization.  
The aim of this thesis is to explore the relationship between the fecal microbiota composition and 
diversity of 2.5 months infants and the striatum volumes measured at one month. This exploratory 
cross-sectional study was conducted using data collected on 56 infants drawn from the FinnBrain Birth 
Cohort study, which focuses on the effects of environmental and genetic stimuli on child development 
and health.  
The results showed no statistically significant associations between alpha and beta-diversity, and the 
striatum volumes. The correlation between alpha-diversity and striatum volumes tended to present 
visible sex-differences, despite their statistical insignificance. This novel study encourages future 
longitudinal studies to provide insight into the relationship between characteristics of the gut 
microbiota and the development of the brain especially during the critical phases of neurodevelopment 
throughout life.  
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We live symbiotically with a community of microorganisms (bacteria, archaea, viruses, 
phages, yeasts and fungi) inhabiting various parts of our body. The gut microbiota, in our 
colon, is one of the best examples of these symbiotic relationships. (Cani, 2018; Cryan et al., 
2019). It is known to have a central role in our general health, as it interacts with virtually all 
of the cells present in our body, including those of the nervous system (Cani, 2018). Besides, 
gut microbiota contributes to several essential metabolic and trophic functions and to 
processes involved in organism protection from infections (Guarner & Malagelada, 2003). 
The existence of the gut-brain axis was first evidenced in the late nineteenth century by the 
pioneering work of Carl Lange and William James, who proposed that signals from the 
viscera to the brain modulated directly some emotional responses (Eisenstein, 2016). Over the 
past decades, our understanding of the gut microbiota's influence on the human brain (e.g., 
metal health or neurodevelopment) broadened and the microbiota-gut-brain research received 
increasing interest. This young and fast-growing area of research questions previous 
paradigms about human capacities by looking at the bidirectional communication between the 
gut and the brain (Hooks et al., 2018; Mayer et al., 2014).  
At present, the main focus of gut-brain research is the investigation of the relationship 
between the microbiota and various aspects of mental health (Christian, 2019) such as stress 
processes, cognition and mood, or neuropsychiatric disorders (Hooks et al., 2018; Mayer et 
al., 2014).  Moreover, the gut microbiota has been shown to have a role in normal 
neurological, cognitive and social development (Desbonnet et al., 2014; Carlson et al., 2018; 
Fröhlich et al., 2016). However, major advances in understanding the microbiota-gut-brain 
were made during research on rodents' models (Sudo et al., 2004; Neufeld et al., 2011), thus 
leading to a scarcity of human-based resources (Hooks et al., 2018; Cryan et al., 2019; 
Carlson et al., 2018).   
Research to date showed that gut microbiota contributes to the phenomenon known as 
'developmental programming' of an organism, especially for the brain. Developmental 
programming is defined as the modulation of a process impacted by environmental factors 
during a sensitive developmental window that has long-term structural and functional effects 
on an organ (Heijtz et al., 2011). Both gastrointestinal microbiota colonization and 
neurodevelopment occurs primarily during the first years of life providing opportunities for 
interactions such as developmental programming. Indeed, the gut microbiota resembles its 
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adult status in humans by the age of three, while foundational neurodevelopment processes 
occur over the first two years of life (Carlson et al., 2018; Gilmore et al., 2012; Knickmeyer et 
al., 2008; Provost, Hanganu, and Monchi, 2015). The close relationship between gut 
microbiota and brain development has been notably demonstrated in germ-free rodent studies, 
which showed that microbiota can have a long-lasting impact on neurodevelopment (Heijtz et 
al., 2011; Sudo et al., 2004). Furthermore, in their study, Neufeld et al. (2011) demonstrated 
that the effects of early disruption of the rodent microbiota establishment might persist even 
after restoring the microbiota using recolonization treatments at the adult stage.  
The ability of gut microbiota to influence neurodevelopment has been highly studied in 
rodents but only sparsely in humans (Hooks et al., 2018; Cryan et al., 2019; Sudo et al., 
2004).  The findings of these clinical studies indicate that gut microbiota diversity correlates 
with temperament, cognitive development and functional connectivity during infancy 
(Aatsinki et al., 2019; Carlson et al., 2018; Kelsey et al., 2019; Yang et al., 2016; Gao et al., 
2019). A highly diverse microbiota is commonly associated with good health; however, this 
idea has been challenged (Shade, 2017; Hooks et al., 2018). Indeed, a study by Carlson et al. 
(2018) revealed that higher levels of bacteria diversity – measured as intra-individual 
diversity (alpha diversity) – was not invariably associated with cognitive development 
benefits in infants. It should be noted that infants’ diet is relatively homogenous (breastmilk 
or formula) and leads to a relatively low microbiota diversity. Indeed, gut microbiota diversity 
increases upon weaning and diversification of diet (e.g., solid foods) and motor development 
(e.g., crawling or walking) which extends the infant’s environmental exposures (Borre et al., 
2014). In all, this suggests that gut microbiota diversity during infancy may have greater, but 
ambiguous, associations with later development compared with adults. 
The deep brain gray matter nuclei, such as the basal ganglia, play a central role in the 
complex networks regulating our behaviours (Provost, Hangaru et Monchi, 2015). The basal 
ganglia, and more specifically their main component the striatum, are essential in the 
functioning mechanisms of the brain’s networks for both motor and non-motor functions 
(Mink & Thach, 1993; Provost, Hangaru et Monchi, 2015). The striatum more specifically 
has been linked to the motor and reward systems (Provost, Hangaru et Monchi, 2015; Mink & 
Thach, 1993). Many neuropsychiatric or neurologic diseases involve the disturbance of the 
striatum's normal functions (e.g., autism, ADHD, Huntington, schizophrenia, Parkinson's 
disease) (Pitenger & Duman, 2008; Liu et al., 2017; Hanganu, 2015; McCutcheon et al., 
2019). Therefore, it is essential to understand the physiology behind the striatum normal and 
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pathological functioning, as it may be vulnerable at various times in life to external factors. 
Hence, the gut microbiota is an external factor that might affect the networking of the 
striatum, particularly in the sensitive window of early life.  
A large body of research targeting the gut-brain axis and its effect on neurodevelopment 
involves preclinical animal model studies and clinical studies on the adult population. Many 
more clinical studies are essential to show the implication of gut microbiota in the striatum's 
structural and functional development. It has been suggested that early life is a sensitive 
period with a higher vulnerability to external factors, similar to the microbiota on the 
behaviour (Sudo et al., 2004). For this reason, studies on children, and even more so on 
infants, are essential to examine the origins of the role that early gut microbiota diversity 
plays in the structural development of the brain and in particular in the striatum. 
1.1 Microbiota-Gut-Brain Axis  
Studies of the gut microbiota have shown that the bacterial cells' genetic material 
outnumbers human genetic material by a hundred-fold (Gilbert et al., 2018). Notably, the gut 
microbiota affects major physiological processes, including immune system functions or the 
biosynthesis of multiple molecules (e.g., vitamins, neurotransmitters) (Huttenhower et al., 
2012; Koenig et al., 2011) and the metabolism of toxins and drugs (Rekdal et al., 2019). 
Hence, it is crucial to understand the gut microbiota development and how it communicates 
with the central nervous system.  
1.1.1 Developmental windows for the gut and brain developments  
Early life is a turbulent time for development, and prenatal and postnatal periods are 
crucial developmental windows characterized by rapid and considerable evolution in the 
neuronal and microbial organization. Brain development involves an intricate equilibrium 
between genetic and environmental factors, that if disrupted may have long-term impacts on 
the brain and individual behaviour later in life (Borre et al., 2014). The nervous system 
undergoes a coordinated series of temporally regulated neurodevelopmental events pivotal for 
functional, cognitive, motor and emotional development. Neurodevelopment begins in utero 
and evolves during postnatal development and throughout the lifespan (Ben-Ari, 2013; Borre 
et al., 2014; Workman, 2013). Presumably, early life disturbances during gut microbiota 




Prenatal development of the microbiota and the brain 
The initial establishment of the gut microbiota is a crucial step in neonatal 
development, although its early timing contradicts the current dogma that the fetal and 
intrauterine environments are sterile (Aagaard et al., 2014; Kuperman et al., 2020; Olomu et 
al., 2020; Rackaityte et al., 2020). The suggested intrautero microbial colonization may result 
from a microbial translocation from the mother to the fetus via the placenta and bloodstream. 
Several preclinical and clinical studies have demonstrated the presence of a bacterial signature 
similar to that of the mother's oral cavity, in the umbilical cord blood, placenta, amniotic 
fluid, and meconium (Funkhouser & Bordenstein, 2013; Jiminez et al., 2005; Aagaard et al., 
2014; Borre et al., 2014). However, the idea of intrautero colonization is debated, as detection 
of bacterial DNA does not establish a causal link proving fetal gut microbial colonization 
(Koren et al., 2012; Perrez-Muños et al., 2017). Rather, it should be thought of as fetal 
microbial exposures which may participate, for example, in immunological programming of 
the fetus (Buffington et al., 2016). Of significance, this intrauterine fetal microbial exposure 
window, and potential gut colonization, is overlapping with the intricate prenatal window for 
brain development.  
Brain development begins as early as 3-4 weeks of gestation with the phenomenon of 
neurulation. This first significant neurodevelopmental process leads to the formation of the 
neural tube critical to normal development (Rice & Baronne, 2000; Stilles et al., 2010). Next, 
neurogenesis, gliogenesis and synaptogenesis conduct to the formation of neurons, glial cells, 
and synapses, respectively. These processes are predominant during gestation but can last up 
to late infancy (2.5 years of age), especially synaptogenesis (Workman et al., 2013, Stilles et 
al., 2010). The concomitant developmental phases of neurons, glia and synapses formation 
insures the appropriate establishment of neuronal-glial interactions (Barker & Ullian, 2010). 
Furthermore, the developing brain is highly vulnerable to both internal and external 
environmental influences. Maternal health plays a crucial role in microbiota and brain 
development and characterization, as it vectors internal and external cues affecting fetal 
development. Indeed, prenatal maternal diet, infection and stress have been associated with 
certain neurodevelopmental disorders such as autism and attention deficit hyperactivity 
disorder (ADHD) (Donnet-Hughes et al., 2010; Bale et al., 2010). Hence, during this sensitive 
window for brain development, maternal microbiota translocation might have an incidence on 
neurodevelopmental disorder risk later in life.  
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Postnatal development of the microbiota and the brain 
The gut microbiota is inoculated at birth, but undergoes significant changes in its 
composition at the introduction of solid foods and weaning (Stewart et al., 2018; Bäckhed et 
al., 2015). During birth, infants are exposed to microbes originating from their mother and, 
toa lesser extent, from external environment. The inoculation and subsequent development of 
the gut microbiota in early life are crucial for health outcomes, particularly neurodevelopment 
(Stewart et al., 2018; Bäckhed et al., 2015; Borre et al., 2014). The diversity of the microbiota 
is at first low and unstable. However, many factors may influence the gut microbiota's 
composition and its functions during this sensitive period. Birth mode, gestational age, and 
genetic and environmental factors (e.g., feeding mode) are key factors influencing the gut 
microbiota's initial composition (Borre et al., 2014). The introduction of solid food and 
weaning leads to a significant change in the gut microbiota composition as diet is a crucial 
modulator of microbiota (Borre et al., 2014; Sudo et al., 2014). The adult-like core 
microbiome develops through a progressive change in the composition and diversity of the 
microbiota. During the first weeks of life, the infant’s fecal microbiota changes from a low 
diversity of facultative anaerobic bacteria to a higher diversity of strictly anaerobic bacteria 
(Bäckhed et al., 2015, Ferretti et al., 2018; Palmer et al., 2007). Full colonization takes 
approximately three years of age (Koening et al., 2011; Weng & Walker, 2013).  
The brain, unlike most organs, undergoes critical development steps during the 
postnatal period when significant morphological growth, cell differentiation, and functional 
acquisition occur (Borre et al., 2014). Synaptogenesis increases throughout infancy and 
synaptic density reaches its highest value at two years of age when the brain has about twice 
as many synapses than the adult brains (Herschkowitz et al., 1997; Stilles et al., 2010). 
Following this synaptogenesis phase, elimination of synapses is necessary for developmental 
remodelling, a refinement process that strengthens and consolidates neuronal circuits acquired 
during childhood's neurobehavioral development (Borre et al., 2010). Furthermore, neuron-
glia interactions are being defined and play a critical role in networks' functional organization 
throughout postnatal life. However, the current understanding of these processes is limited to 
human post-mortem data and extrapolation of findings from other species. Current research 
using in vivo imaging of children provides information about the temporal evolution of the 
developmental processes and how they connect to the evolving behaviours (Stilles et al., 
2010). Information is also provided by magnetic resonance imaging – commonly used in 
children – which allows monitoring of the changes in tissue chemistry thought time, and 
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subsequent correlation with neural and glial proliferation and migration gives insight into the 
timing and anatomical distribution of the neurodevelopmental events (Barkovich, 2000; 
Barkovich, 2005). Finally, in vivo imaging studies are required to gain more profound 
knowledge regarding the dynamic interactions within the human brain tissue with a molecular 
and microstructural view (Stilles et al., 2010).  
1.1.2 Gut-Brain Axis bidirectional communication with the brain 
Over the last decades, the gut-brain axis communication's bidirectional nature has 
been elucidated, in which the microbiota plays a significant role (Cryan & Dinan, 2012; 
Evrensel & Ceylan, 2017; Hoban et al., 2016). The microbiota carries out its actions 
(protective, metabolic and trophic) by influencing immunologic, endocrine and neural 
pathways. These three psychoneuroimmunologic (PNI) pathways allow the microbiota to 
influence brain functions and neurodevelopment (Desbonnet et al., 2014; Heijtz et al., 2011; 
Hoban et al., 2018; Sudo et al., 2004) via mediation by cytokines, the hypothalamic-pituitary-
adrenal axis (HPA) and the vagus nerve (Grenham et al., 2011, Yang et al., 2016).  
Immune pathway  
The immune system activity is essential in various brain processes (Dantzer, 2018; 
Morimoto & Nakajima, 2019; Dantzer & Wollman, 2003). As a result, the variation in 
microbiota and the resulting modulations in the immune system actions forms a potent 
pathway in microbiota-gut-brain-axis communication. The gut microbiome (the 
microorganism and their collective genetic makeup) contributes to the host's systemic 
inflammatory milieu by low-level leakage of bacteria and their component across the luminal 
intestinal interface (Duerkop et al., 2009). Throughout early life, the gut microbiota is an 
essential component of both innate and adaptive immune system development (Olszak et al., 
2012). In the infant, early life dysbiosis of the microbiome may impact the developing 
immune system with a higher risk of developing an inflammatory disease (Yang et al., 2016). 
Moreover, gut microbes and/or their secretions can affect both the pro-inflammatory and the 
anti-inflammatory mediators essential for general immune homeostasis (Wu & Wu., 2012; 
Lee et al., 2011). For instance, levels of pro- and anti-inflammatory immunes mediators (e.g., 
cytokines) seem to alter behaviour and neurochemistry in rodents (Miller et al., 2013). In 
adults, an excessive presence of pro-inflammatory species (e.g., gram-negative 
Enterobacteriaceae) causes chronic low-grade inflammation, whereas the dominance of anti-
inflammatory species (e.g., Lactobacillus) maintains a milieu inhospitable to pro-
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inflammatory species (Adams & Hall, 1988; Haarman & Knol, 2006). Hence, the relation 
between the gut microbiota and the immune system activity is bidirectional and complex 
(Maynard et al., 2012).  
Endocrine pathway  
The microbiota's makeup affects the hypothalamic-pituitary-adrenal (HPA) axis, the 
primary stress regulation system (Sudo et al., 2004). The HPA axis is the central 
neuroendocrine system controlling cortisol output, a key regulator of glucose, protein, and 
lipid metabolism and immune responses (Bellavance & Rivest, 2014). Modulation of HPA 
axis function by the gut microbiota directly influences cortisol secretions and the normal 
development of the stress response (Sudo et al., 2004; Sudo et al., 2014) and indirectly 
influences activation of the HPA axis by pro-inflammatory cytokines (Ekenkov & Chrousos, 
2002). During early life, HPA axis development and functioning are intertwined with specific 
bacteria colonizing the gut, such as Bifidobacteria (O'Mahony et al., 2017; Sudo et al., 2004). 
This microbiota-endocrine interplay is essential because various disorders of the microbiota-
gut-brain axis (e.g., ADHD) might be associated with dysregulation of the HPA axis 
(Isaksson et al., 2012). 
Neural pathway 
The microbiota and/or its metabolic products may affect the nervous system 
innervating the gastrointestinal tract, including the autonomic nervous system (Wehrwein et 
al., 2016) and the enteric nervous system. The vagus nerve is a significant component of the 
autonomic nervous system, specifically the parasympathetic nervous system, and consists of 
afferent (80%) and efferent neurons. Also, it plays an essential role in microbiota-gut-brain 
communication. Hormonal, chemical, mechanical and nociceptive information from 
microbiota signals stimulates vagus nerve afferent endings and reaches the central nervous 
system (Berthoud et al., 2004; Egerod et al., 2018; Yang et al., 2016). Therefore, the output 
from the afferent endings may affect behavioural and efferent neuronal activity. However, in 
the early postnatal life, the vagus is not fully functional as it is only partially myelinated 
(Porges and Furman, 2011). Thus, signals from the gut microbiota may be altered during 
vagus nerve myelination in early postnatal life. Moreover, activation of afferent outputs is 
thought to be responsible for our "gut-feelings". Similarly, pro-inflammatory cytokines 
provide information regarding systemic inflammation (Yang et al., 2016). The enteric nervous 
system, mesh-like system within the gastrointestinal tract, works in conjunction with the 
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autonomic nervous system to ensure proper functioning and regulation of gut functions (e.g., 
motility). The enteric nervous system is sensitive to microbial metabolites (Mao et al., 2013; 
Hyland and Cryan, 2016), and its normal function is essential for microbiota stability (Rolig 
et al., 2017). Additionally, gut serotonin signalling potentially mediate gut microbiota 
influence in enteric nervous system maturation (De Vadder et al., 2018).   
Basal metabolites 
In addition to the three PNI pathways, it has long been known that the gut microbiota 
produces metabolites that may also act as neurotransmitters (Yano et al., 2015). The majority 
of serotonin biosynthesis occurs in the intestinal tract via enteroendocrine cells present in the 
epithelium and is promoted by gut microbiota (Yano et al., 2015). Similarly, biosynthesis of 
gamma-ammino-butyric acid (GABA) and dopamine (DA) is also predominantly done in the 
intestines by the gut microbiota (Dinan et al., 2015; O'Mahony et al., 2017). However, it is 
unknown how the neurotransmitters and the microbiota interact, to what extent these 
neurotransmitters are systemically absorbed and cross the blood-brain barrier, and what are 
the significant effects on neurodevelopment (Jameson et al., 2020;). 
Apart from neurotransmitters, the gut microbiota is known to metabolize and utilize amino 
acids and short-chain fatty acids (SCFA). Amino acids play a role in neurotransmitter 
synthesis (Choi et al., 2009; Gao, Mu, Farzi & Zhu, 2020), whereas SCFAs are fermentation 
products of complex carbohydrates (Dalile et al., 2019), modulating immunity, metabolism 
and epigenetic programming (Krautkramer et al., 2016). Microbiota interventions may affect 
the central nervous system via alteration in amino acid metabolism (Olson et al., 2018) or 
SCFA levels (Bishehsari et al., 2018; Goswami et al., 2018).  
1.1.3 Studying the relationship between the gut microbiota and the brain structural 
and functional development  
Studying the microbiota  
To understand the role of the gut microbiota on human health, researchers such as the 
Human Microbiome Project, aimed to characterize the microbiota composition and diversity. 
Traditionally, gut microbiota's characterization has been performed with selective in vitro 
culture methods, however with a limited range of identification. More recently, culture-
independent methods have been used, including fluorescent in situ hybridization, gel 
electrophoresis, 16S ribosomal RNA cloning, sequencing, and quantitative polymerase chain 
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reaction (PCR) (Brooks, 2013). These more contemporary molecular methods are widely used 
in studies of the microbiota.  
All bacteria have a highly conserved 16S ribosomal RNA gene containing 
hypervariable regions (Morgan & Huttenhower, 2014). Amplicon sequencing, also known as 
16S rRNA sequencing, allows the amplification of these hypervariable regions, with a PCR 
followed by sequencing, and thus, obtention of an estimate of the proportions of detected 
bacteria in the sample (Morgan & Huttenhower, 2014; Cryan et al., 2019). However, despite 
being widely used for its low cost, the 16S rRNA sequencing is prone to limitations. For 
instance, PCR primer, amplification and accuracy biases are most notable because the 16S 
gene is subject to copy number variation. Furthermore, 16S rRNA sequencing limits reliable 
taxonomic annotation to the genus level and provides no information the genome or function 
of the detected bacteria (Morgan & Huttenhower, 2014). Shotgun metagenome (whole DNA) 
or metatranscriptome (whole RNA) sequencing yields information on the microbiota's 
functional capacity or functions at the species, gene or gene expression level. Furthermore, 
shotgun sequencing provides abundance estimates for bacteria, archaea, fungi and viruses, 
whereas 16S rRNA sequencing is limited to abundance estimates for bacteria (Morgan & 
Huttenhower, 2014). The late narrowing in cost difference between 16S rRNA sequencing 
and shotgun sequencing resulted in two-stage experiments integrating the two methodologies 
(Morgan & Huttenhower, 2014; Tickle et al., 2013). 
Molecular methods have been critical in studying microbial communities in health and 
disease. Indeed, the characteristics and function of gut microbiota have been associated or 
implicated with, for example, the development of metabolic disease (Koh and Bäckhed, 2020) 
or plays a mechanistic role in the pathogenesis of neurological diseases such as multiple 
sclerosis (Cekanaviciute et al., 2017) and Parkinson's disease (Sampson et al., 2016; Baizabal-
Carvallo and Alonso-Juarez, 2020). Hence, information about the gut microbiota's role in the 
underlying mechanisms may open doors for new interventions.  
Studying the Microbiota-Gut-Brain Axis in animal models 
In recent decades, the interplay between brain functioning, behaviour and gut 
microbiota has begun to be elucidated (Cryan et al., 2019; Hooks et al., 2018). In vivo 
models, especially rodents, under germ-free (GF) conditions are an essential starting point in 
understanding the gut microbiota's effects on brain functions and behaviour (Evrensel & 
Ceylan, 2017). Indeed, GF models demonstrated that the absence of microbiota in early life 
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influences multiple aspects of neurodevelopment (Borre et al., 2014) and leads to altered 
behaviour (Heijtz et al., 2011; Neufeld et al., 2011), social functioning (Desbonnet et al., 
2014; Cryan & Dinan, 2015) or stress responsivity (Sudo et al., 2004). Similarly, GF 
conditioning leads to modification in levels of neurochemicals, such as neurotransmitters and 
neurotrophic factors (Bercik et al., 2011; Mayer et al., 2014; Sudo et al., 2004), and an 
increased blood-brain barrier permeability (Braniste et al., 2014). The GF rodent models do 
not have clinical correspondence and have limited translatability to humans; therefore, 
observed brain and behaviour differences are restricted to GF conditions. Additionally, dietary 
interventions and antibiotic and probiotics treatments can alter the gut microbiota, leading to 
behavioural and neurochemical changes (Cryan et al., 2019; Sudo et al., 2004). Intriguingly, 
early life microbiota is essential for behavioural outcomes, as changes induced by microbiota 
alterations are reversible by early-life colonization (Heijtz et al., 2011) but not necessarily 
during adulthood (Neufeld et al., 2011). Moreover, the changes caused by non-functional 
microbiota during early life have may been sex specific. On one hand, the neurochemical and 
endocrine effects under GF conditioning are mainly noticeable in male rodents (Cryan & 
O'Mahony, 2011). Contrastingly, female mice showed a reduction in anxiety behaviour and 
increased brain-derived neurotrophic factor (BDNF) (Neufeld et al., 2011). Social 
development is also impacted by gender variability, particularly under GF conditions where 
mice exhibited autistic traits predominantly observed in males (Desbonnet et al., 2014). 
Studying the brain structure and function 
 The emergence of brain imaging techniques in the late 20th century (1980), such as 
positron emission tomography (PET), magnetic resonance imaging (MRI), and diffusion 
tensor imaging (DTI), led to the conclusion that there are interactions between the gut and the 
brain in humans. Brain imaging offers an ideal method for observing the influence of gut 
microbiota on the brain in vivo. Previous studies complementized their experimental imaging 
designs with neuropsychological measures or cognitive testing to evaluate the interactions 
between the microbiota composition and the brain or behaviour in health and neuropsychiatric 
disorders (Cryan et al., 2019).  
MRI techniques (e.g., structural MRI and functional MRI) are widely used because of 
their non-invasive property and provide information regarding the brain's structural, function, 
and metabolic status (Liu et al., 2019). Structural MRI typically assesses gray matter 
structures in terms of volume and thickness, whereas functional MRI assesses cerebral 
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structures in terms of functional changes using indirect measure of regional blood flow (Liu et 
al., 2019). Preclinical studies brought evidence of structural, region-specific changes in GF 
mice's brain (i.e., cortex and hippocampus) in association with gut microbiota products (e.g., 
BDNF) (Sudo et al., 2004). Also, clinical evidence showed sex-dependent variation in cortical 
thickness of the anterior insular cortex and gray matter volume of irritable bowel syndrome 
patients (Weaver et al., 2016). Functional MRI, specifically blood-oxygenation level-
dependent signal (BOLD), is commonly used for studying the neural basis of cognition (Liu 
et al., 2019). This technique generally relies on patient participation because it is tasks-based 
to visualize cerebral responses for specific cognitive processes (Liu et al., 2019). However, 
resting-state BOLD functional MRI can be performed to measure spontaneous cerebral 
activity (Liu et al., 2019). Hence, MRI techniques permit the visualization of the gut-brain 
interactions (i.e., Sudo et al., 2004), when associated with concomitant evaluation or 
modification of the gut microbiota status, and obtention of measurements of the potential 
structural and/or functional changes associated with the microbiota.   
1.2 Microbiota-Gut-Brain Axis relationship with deep brain structures 
The extensive work on animal models provided essential information regarding the 
microbiota-gut-brain axis's principal mode of action. However, the literature that translate 
preclinical information to human populations, especially infants, is substantially scarce. 
Despite investigations regarding the microbiota-gut-brain axis association with 
neuropsychiatric or neurodevelopmental disorders, there is a critical need for further studies 
on healthy infant populations. Indeed, unravelling the relationship between the gut microbiota 
and the brain structure and function in early life would provide a critical understanding of the 
origins of the microbiota-gut-brain axis and its neurodevelopmental association.   
1.2.1 Microbiota-Gut-Brain Axis bidirectional communication in clinical studies 
The microbiota-gut-brain axis seems to be implicated in multiple neuropsychiatric 
disorders, especially in depression (Bastiaanssen et al., 2018; Ding et al., 2019). Indeed, some 
evidence demonstrated probiotics' ability to modulate clinical depressive symptoms, yet 
limited studies focus on depression (Ng et al., 2018; Kelly et al., 2016).  Additionally, studies 
suggested a possible association between the gut microbiota and other neuropsychiatric 
disorders, such as bipolar disorder (Hu et al., 2019; Gondalia et al., 2019) or rodent models 
for schizophrenia (Zheng et al., 2019). Also, several studies investigated the implication of the 
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microbiota-gut-brain axis in the development of neurodevelopmental disorders, such as 
autism and attention-deficit hyperactivity disorder (ADHD) (Bundgaard-Nielsen et al., 2020). 
They demonstrate a clear difference in fecal microbiota composition between autistic patients 
and healthy controls, with autistic patients possessing a greater gut microbiota beta-diversity, 
but this variation has not been consistently reported in the literature (Bundgaard-Nielsen et al., 
2020; Finegold et al., 2010). Similar findings were found for ADHD, as gut microbiota is 
seen as an important external factor linked to the development of ADHD (Bundgaard-Nielsen 
et al., 2020; Cenit et al., 2017). In all, these observational studies on neuropsychiatric and 
neurodevelopmental disorders suggest the presence of a lifelong communication between the 
microbiota, the gut and the brain in humans. However, further studies should focus on early 
life associations between the gut microbiota and brain structure and function.  
1.2.2 Association between fecal microbiota and brain structure and function during 
infancy or childhood 
Only recently, microbiota-gut-brain studies have reported associations between fecal 
microbiota and brain structural and functional differences during infancy or childhood (Gao et 
al., 2019; Carlson et al., 2018; Callaghan et al., 2019; Sordillo et al., 2019). Despite being 
limited, they provide foundational information regarding microbiota influence on brain 
structure and function in early life. A study by Carlson et al. (2018) provided initial evidence 
of associations between gut microbiota and cognitive performance during infancy. Their 
results show a correlation between higher alpha diversity and lower Mullen Early Learning 
Cognitive Composite (ELC) scores at two years of age. They also evaluated the correlation 
between alpha diversity and various cerebral volumes and found a negatively directed 
association between alpha diversity and volumes for the amygdala, the left precentral gyrus 
and the right angular gyrus. Another study by Gao et al. (2019), interested in the brain's 
functional connectivity during infancy, provided primary evidence that microbiota diversity 
was associated with functional connectivity of neural circuits essential in cognitive 
development. Specifically, they showed a strong association between alpha diversity and 
weaker functional connectivity for two networks (ie., the amygdala and thalamus; the anterior 
cingulate cortex and anterior insula) (Gao et al., 2019). Besides, microbiota composition in 
infants has been associated with functional reactivity in brain networks of fearful faces 
(Callaghan et al., 2019) and developmental ages and stages (Sordillo et al., 2019). 
Communication, personal, social, and motor developmental scores appear to associate with 
particular bacterial genus abundances (e.g., Bacteroides and motor scores) (Sordillo et al., 
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2019). Similarly, different bacterial genus abundances associate positively with different 
cerebral structures involved in the fear processing network (Callaghan et al., 2019). 
Moreover, studies showed an association between microbial diversity and cognitive and 
emotional functioning (Aatsinki et al., 2019; Carlson et al., 2018, Christian et al., 2015). 
Temperament, the innate part of character affecting our moods and behavior (i.e., self-
regulation and emotional reactivity) (Rothbart, 2011), has been associated with microbiota 
alpha and beta diversity, specifically regarding fear reactivity and negative emotionality 
(Christian et al., 2015; Aatsinki et al., 2019).  
In all, the emerging studies focusing on the interplay between the gut microbiota and 
brain structural (e.g., volumes) and functional (e.g., cognition, functional networks) 
development in early life show promising results. Indeed, they expend the current information 
obtained from preclinical studies as well as neurodevelopmental studies. Furthermore, 
specific structures, such as the amygdala, appear to be significantly influenced by the 
microbiota-gut-brain axis in health and neurodevelopmental studies. The recent studies by 
Gao et al. (2019) and Carlson et al. (2018) showed an association between the microbiota 
characteristics and the amygdala volume and functional connectivity. Hence, further research 
to expand our knowledge of microbiota-gut-brain influence on brain structures critical for 
neurodevelopment and healthy functioning, such as the striatum, is necessary.  
1.2.3 The striatum is a critical component of the motor and cognitive systems 
The basal ganglia regroup nuclei are located in the most central regions of the brain. 
They are composed of two principal structures, the striatum and the pallidum—each of these 
structures regrouping multiple nuclei. The striatum is composed ventrally by the caudate 
nucleus and the putamen, and dorsally, the nucleus accumbens. The pallidum regroups the 
globus pallidus (external and internal) and the substantia nigra. This organization of the basal 
ganglia structures rests on the functional subdivision of each nucleus. Indeed, the striatum and 
the pallida are the basal ganglia's input and output zones, respectively. The basal ganglia are 
involved in movement modulation (Mink & Thach, 1993) and non-motor functions 
implicating prefrontal and limbic pathways necessary for cognitive and emotional processing 
(Provost, Hangaru et Monchi, 2015).  
The striatum is the principal component of the basal ganglia, which receives afferent 
information from the cerebral cortex and relays it to different structures in order to feedback 
the processed information to the cortex (Zorumski & Rubin, 2011). It is composed of three 
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nuclei, the caudate nucleus, the putamen and the nucleus accumbens. Moreover, the striatum 
is essential for both motor and non-motor functions of the basal ganglia. Movement 
modulation principally involves medium spiny neurons (MSNs) of the caudate nuclei and 
putamina, together with cortical neurons. Additionally, the corticostriatal pathway integrates 
afferent information with a functional and topographical organization (Goldman-Rakic & 
Selemon, 1990; Mink & Thach, 1993). Indeed, this highly conservative functional and 
topographical organization is also reflected in the striatum's microstructure, such as the nature 
of its synapses (e.g., glutamatergic, serotonergic, GABAergic and dopaminergic) (Goldman-
Rakic & Selemon, 1990). More recently, along with the generalization of imaging techniques 
in experimental designs, the striatum's implication in the non-motor brain process has been 
unravelled (Provost, Hangaru and Monchi, 2015). Together with the frontal cortex and limbic 
structures, such as the dorsal prefrontal cortex, the anterior cingulate and the orbitofrontal 
cortex, the striatum plays a crucial role in cognitive and emotional mechanisms (Provost, 
Hangaru et Monchi, 2015). Hence, it has been suggested that disruptions in the functions of 
the striatum might be involved in the development of neurological and neuropsychological 
disorders, such as Parkinson's disease (Hanganu, 2015; Zhai et al., 2018), schizophrenia 
(McCutcheon et al., 2019), or depression (Pitenger & Duman, 2008; Liu et al., 2017). 
Furthermore, the striatum's involvement in these disorders' pathophysiology may be related to 
the variation of neurotransmitters expression (dopamine, glutamate, GABA, or serotonin), 
critical to these disorders in the striatum (The Human Memory, 2019).  
 During prenatal development, the striatum emerges from the ventral subdivision of the 
forming telencephalon (Onorati et al., 2014). Furthermore, the striatum's differentiation 
occurs in a very narrow temporal window (6-11 weeks of development) and is dependent on 
specific transcriptional dynamics involving about 90 genes (Onorati et al., 2014). Based on in 
vitro evidence, the striatum neurons are functional, showing spontaneous activity capabilities 
and specific ionic and synaptic conductance in response to neurotransmitter modulation 
(Onorati et al., 2014). Throughout infancy, brain growth is important to reach about 80-90% 
of its adult volume (Heijtz, 2016). Indeed, a net increase of gray matter volumes, including 
the striatum, has been observed and may correlate with crucial cognitive development 
(Knickmeyer et al., 2008). Most specifically, the caudate nucleus volume increases 
significantly between the age of one and two years, which may correlate with motor 
development, as it is a critical structure of movement modulation (Herrero et al., 2002; 
Knickmeyer et al., 2008). Excessive growth of the caudate nucleus has been associated with 
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the repetitive behaviours observed in autism (Qiu et al., 2014). However, there is limited 
literature regarding the development of the striatum in humans. 
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2 Aims of the thesis  
Central aspects of gut-brain axis research inspect microbiota influences on cognition, 
mood, neurodevelopmental and psychiatric disorders (Hooks, Konsman, and O'Malley, 2018; 
Ding et al., 2019). Furthermore, it has been shown that deep brain structures are critical 
components of both gut-brain and neurodevelopment research (Zorumski & Rubin, 2011). 
Gut-brain axis studies extensively focused on gut microbiota influence the role and structure 
of the various deep brain component such as the amygdala both in health and pathology 
(Carlson et al., 2018; Gao et al., 2019; Callaghan et al., 2019; Srodillo et al., 2019). Despite 
studies of the brain's development (Gilmore et al., 2011; Knickmeyer et al., 2008; Provost, 
Hanganu, and Monchi, 2015), including the striatum, the relationship between the gut 
microbiota and the striatum is currently not of interest, although the crucial importance of the 
early years of life for neurodevelopment and gut colonization has been extensively reviewed 
(Borre et al., 2014; Jena et al., 2020; Kelsey et al., 2019). However, microbiota-gut-brain 
studies failed to understand the origins of the relationship between gut microbiota and brain 
functions in early life (Carlson et al., 2018). As of today, only a few studies have begun to 
develop our understanding of the gut-brain relationship in early life (Gao et al., 2019; Carlson 
et al., 2018; Callaghan et al., 2017; Sordillo et al., 2019). The study by Carlson et al. (2018) 
suggested an association between microbial diversity in the gut, cognitive development and 
various cerebral volumes. However, their results showed an absence of association at one or 
two years of age between the gut microbiota diversity and the caudate nucleus. Hence, to 
address the paucity of the current literature, further studies are needed to understand the 
microbiota-gut-brain axis concerning early life events.  
This cross-sectional exploratory study will examine the origins of the gut-brain relationship, 
especially the interplay between the microbiota composition and diversity and the striatum's 
volumes. Specifically, the study will examine how the composition and diversity of infant 
fecal microbiota at the age of 2.5 months are associated with striatum volumes, particularly 
the caudate nuclei and putamina, at approximately one month and whether a sex-specific 
interaction is present among these associations.  
We hypothesize an observation of associations (positive or negative) between the gut 
microbiota diversity and the striatum volumes as previously suggested for particular 





The study population (n=56; 24 boys and 32 girls) is drawn from the ongoing FinnBrain 
Birth Cohort study conducted in South-West Finland (www.finnbrain.fi, Karlsson et al., 
2018), which has been approved by the Ethics Committee of the Hospital District of 
Southwest Finland. Criteria of infant’s inclusion were usable fecal samples and structural 
magnetic resonance imaging data. Among the ~200 available infant scans with measures of 
striatum volumes, only 56 also provided fecal samples for microbiota evaluation. The 
FinnBrain research group aims to study the combined influences of genetic and environmental 
factors during early life on posterior child development and health outcomes. Recruitment of 
families lasted from December 2011 until April 2015 and was done during the first ultrasound 
appointment in maternity clinics. In the invited parents, 66% agreed to participate in the 
cohort study. A total number of 3837 children are taking part in the birth cohort study. All 
mothers provided written informed consent on behalf of their child. The details of the 
recruitment of cohort participants (both children and their parents) are detailed in a previous 
paper by Karlsson et al. (2018). 
3.2 Covariates 
Mothers provided background information through self-report questionnaires both 
prenatally and postnatally, as described in Aatsinki et al. (2019). Prenatal questionnaires were 
filled at gestational weeks (gwk) 14 and 34. Prenatal information included the level of 
mother's education (1: university education, 2: vocational school diploma, 3: secondary level 
education or equivalent diploma) and the maternal use of selective serotonin reuptake 
inhibitors or serotonin-norepinephrine reuptake inhibitors (SSRI/SNRI). Postnatal 
questionnaires provided information on infant antibiotic use and feeding mode in months. The 
breastfeeding variable was categorized as no breastfeeding, partial breastfeeding, exclusive 
breastfeeding, and ceased before 2.5 months of age, according to Stewart et al. (2018). Data 
on maternal pre-pregnancy body mass index (BMI; kg/m2), infant's birth weight (g), height 
(cm), duration of gestation (weeks; preterm <37 gwk, term 37-41 gwk, post-term ≥ 41 gwk), 
antibiotics intake during the neonatal period, and the mode of delivery (caesarian-section or 
vaginal) was collected from National Birth Registry provided by the National Institute for 
Health and Welfare (www.thl.fi) (Karlsson et al., 2018).  
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3.3 Acquisition of subcortical gray matter structures volumes 
3.3.1 MRI acquisition 
The magnetic resonance images (MRI) were obtained with a Siemens Megnetom 
Verio 3T scanner (Siemens Medical Solutions, Erlangen, Germany). The acquisition protocol 
has been described in detail by Lehtola et al. (2019). The subjects underwent a 40-minute 
protocol during normal sleep. This protocol included two scanning sequences: (1) an axial 
PD-T2-TSE (Dual-Echo Turbo Spin Echo with repetition time [TR]: 12 070 ms, effective 
echo times [TE]: 13 ms and 102 ms) and (2) a sagittal 3D-T1 MPRAGE (Magnetization 
Prepared Rapid Acquisition Gradient Echo with TR: 1900 ms, TE: 3.26, inversion time: 900 
ms). All images obtained were medically assessed by a neuroradiologist for incidental 
findings.   
3.3.2 Assessment of structure volumes 
The left and right caudate nuclei and putamina volumes were assessed via a template 
library and a label-fusion-based method. The procedure for assessing volumes has been 
previously described in detail by Acosta et al. (2020). Simply, it has three steps. First, the 
construction of a template library-specific to the population at hand and the manual labelling 
of all the subcortical structures of interest. Second, the construction of a library of wrapped 
versions of the labelled template allows a representation of the morphological variations. 
Third and last, the individual labelling of each subject's scans by performing a label-fusion-
based method and calculating deep gray matter structure volumes. A label-fusion method is 
used for individual segmentation, and the approach uses a population-specific template library 
for the structure of interest (i.e., caudate nucleus and putamen). The method used, based on 
label-fusion, is described in Acosta et al. (2020) and emanates from complementary works of 
Coupé et al. (2011), Weier et al. (2014), and Lewis et al. (2019) (Figure 1).  
The mean and standard deviation for the calculated volumes of the left and right 
striatum (caudate nuclei and putamina) for the whole sample (N=56) and, independently, for 




Figure 1. Assessment of the structure volumes protocol simplified from Acosta et al. (2020).  
3.4 Acquisition of intestinal microbiota composition and diversity 
Gut-microbiota characterization is complicated as the microbiota contains 100 times the 
human genome's genes (Eckburg et al., 2005). However, it is facilitated by rapid sequencing 
techniques in combination with bioinformatics. Once the fecal samples (gut microbiota) have 
been collected, they undergo a DNA extraction protocol followed by a 16S ribosomal RNA 
(rRNA) gene V4 region sequencing protocol. The 16S gene is composed of 9 hypervariable 
regions (V1-V9). The V4 region is commonly used for its size (~254 bp) and its low 
divergence in length (www.illumina.com, Application Note: Sequencing).  
16S rRNA sequencing is a well-established method as a measure of microbial 
community structure and diversity. The 16S gene is universal across bacteria and archaea, 
thus making it an extensively used marker. The 16S sequences are phylogenetically 
informative allowing extrapolation of the microbial taxa. Although very common for 
comparison of samples phylogeny and taxonomy, 16s rRNA sequencing is limited. Indeed, 
microorganisms often have multiple copies of the 16S gene in their genome. Hence, the 
observed fluctuation in the 16S gene during sequencing can be explained both by variation in 
genomic 16S copy number and in the abundance of microorganisms (Kembel, Wu, Eisen, & 
Green, 2012). 
3.4.1 Fecal sampling and 16S sequencing  
The infant's fecal sample data was drawn from the FinnBrain study. Fecal sampling is 
an ideal collection method as it is non-invasive and easily performed at home for a target 
population of infants. Fecal samples were collected at approximately 2.5 months of age (age 
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mean = 10.4 weeks, SD = 1.8) at home by the parents as previously described in more detail 
by Aatsinki et al. (2019). Parents were instructed orally and in writing to collect a stool 
sample into a sterile collection tube, marked with the sampling's date and time. The sample 
tube was immediately stored either refrigerated or frozen until delivered with coolers to the 
study rapidly after the collection. Samples delivered to the study center within 48 hours after 
sample collection were homogenized by gentle mixing, weighed into aliquots, and frozen at -
75°C until DNA extraction.  
Bacterial DNA was extracted from 100 mg sample aliquots with GXT Stool 
Extraction Kit VER 2.0 (Hain Lifescience GmbH, Nehren, Germany). The extraction was 
otherwise performed according to the manufacturer's instructions. However, sample vortexing 
was replaced by homogenization with MOBIO PowerLyzer 24 Bench Top Bead-Based 
Homogenizer in 0.1mm glass bead tubes (MO BIO Laboratories, Inc., Carlsbad, CA, USA) at 
1000 rpm for 3 minutes to induce cell lysis. The DNA concentrations were measured with 
Qubit dsDNA HS Assay kit and Qubit 2.0 fluorometer (Thermo Fisher Scientific, Waltham, 
MA, USA), and the DNAs were stored at -75°C. To analyze the fecal microbiota profiles, 
variable region V4 of the bacterial 16S rRNA gene was amplified with custom-designed dual-
indexed primers and sequenced with Illumina MiSeq system as previously described by 
Rintala et al. (2018). 
3.4.2 Obtention of Amplicon Sequence Variants (ASVs) and Shannon index of 
diversity 
The raw sequences from the 16S rRNA gene sequencing were preprocessed with 
DADA2-pipeline (version 1.14) to infer exact amplicon sequence variants (ASVs) (Callahan 
et al., 2016). The reads were truncated to length 225 and reads with more than two expected 
errors were discarded (max EE = 2). Genome taxonomy database (GTDB, release 86) (Parks 
et al. 2020)  and RDP Naive Bayesian Classifier algorithm (Wang et al. 2007) were used for 
the taxonomic assignments of the ASVs. The phylogenetic tree was constructed with package 
phangorn (Schliep 2011). The resulting sample had 14k-255k (mean = 83k, SD = 57k) reads 
per sample. The ASVs are used to determine the beta diversity and the differential abundance 
of the sample's microbiota.  
Alpha diversity Shannon Index was determined with microbiome R package, on R 
software 3.5.0 (McMurdie and Holmes, 2013). Shannon Index was measured to present the 
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microbiota community's species diversity, as it a commonly used index in microbial studies 
(Shen, Zhang, Zhu, Zhang, & He, 2008).  
3.5 Statistical analysis 
The statistical analyses were performed with R 4.0.1. software (R Core Team, 2020). 
The R package tidyverse has been added to base R packages because it includes a set of 
functions, data, and documentation, necessary for the analysis (Wickham & Grolemund, 
2016). The dependent variables were the right and left striatum volumes, i.e., caudate nuclei 
and putamina. The independent variables regrouped the gut microbiota parameters alpha and 
beta diversities. Covariate variables were chosen from theoretical assumptions formulated in 
existing literature (Pulli et al., 2018; Carlson et al., 2018; Gao et al., 2019). Covariates were 
assumed to be associated with either the independent or dependent variables – thus, those 
included in the analysis were sex, delivery mode, gestational age (at birth), age at fecal 
sampling, age at scan from birth, feeding mode (at the age of fecal sample) and birth weight. 
Antibiotic treatment was excluded from covariates, despite inclusion in previous literature, as 
it was poorly reported in the questionnaires and thus, was potentially relevant for only five 
infants. Furthermore, the significance level (alpha) was defined at 0.05 level. Shapiro-Wilk 
test was used to test the normality of the distribution for all the variables. Shannon Index (gut 
microbiota alpha diversity) and the striatum volumes were normally distributed (Table 1).  
Table 1. Shapiro-Wilk test results for the independent and dependent variables. For statistical 
significance p-value <0.05.  
Variable Shapiro-Wilk test W p-value 
Shannon Index  0.98 0.57 
Striatum volumes Left Caudate Nucleus 
Right Caudate Nucleus 
Left Putamen  









3.5.1 Associations between alpha diversity and striatum volumes, and sex 
differences exploration  
The exploration of potential associations between the striatum volumes and alpha 
diversity (Shannon Index) was performed in R software, starting with a Spearman correlation 
coefficient test. Additionally, linear regression models were run for associations between the 
alpha diversity and the left and right caudate nuclei and putamina, with adjustments for the 
defined covariate variables.  
26 
 
Further, sex differences were explored first via stratified analyses of the correlation 
coefficient between sex and alpha diversity. Also, linear regression models were run to 
include an interaction term for sex (sex*diversity). The results obtained are reported on a 
scatter plot, done with the ggplot function of the tidyverse R package. 
3.5.2 Evaluation of sample homogeneity and dissimilarity by calculation of 
microbiota beta diversity and dispersion effect size 
To explore how the fecal microbial communities may differ between each infant, we 
measured the beta diversity and the beta dispersion of the sample. First, visualization of the 
data similarities (or dissimilarities) was obtained by performing a Principal Coordinates 
Analysis (PCoA) (Zuur, Leno & Smith, 2007; Gower, 1966, www.sequentix.de). The PCoA, 
with multi-dimensional scaling ordination of the ASVs, was performed with the microbiome 
and phyloseq packages in R (Lahti et al., 2012-2017) to visualize a summary of the infants' 
fecal beta diversity (genus level) with regards to the dependent, independent and covariate 
variables. Then, the beta diversity, testing whether the microbiota composition among groups, 
here individuals, is similar or not to one another (Goodrich et al., 2014), was investigated. The 
R package vegan's function adonis, which runs a permutational multivariate analysis of 
variance using OTU-wise distances (genus level) matrices (permutations = 999), was used to 
calculate the effect size (R2) of beta diversity for the independent and covariate variables. 
Finally, the beta dispersion, which tests the homogeneity of dispersion of composition among 
samples, here individuals, was investigated for all the covariate variables using the betadisper 
function's ANOVA method, part of the vegan R package. All the results, beta diversity and 
beta dispersion, are reported on PCoA plots, done with the plot_ordination function of the 
phyloseq R package. 
3.5.3 Differential abundance of the gut microbiota 
Differential abundance analyses, used to detect differences in taxonomic composition 
(https://www.biobam.com), were run for the left and right caudate nucleus and putamen, 
controlling for the defined covariate variables. The DESeq2 R package was used to perform 
quantitative analyses of differential expression via shrinkage estimation, resulting in 
identifying bacterial signatures with a statistically significant association with striatal volumes 




This study's main objective is to explore the origins in the infancy of the gut-brain 
interactions, specifically the relationship between the diversity of the intestinal microbiota and 
the brain volumes of the striatum. We expected the presence of associations (positive or 
negative) between the gut microbiota diversity and the striatum volumes as suggested for 
particular subcortical structure in previous literature (Carlson et al.,2018; Gao et al., 2019). 
This exploratory study has been conducted by analyzing previously collected and 
processed data – magnetic resonance images for the striatum volumes and fecal samples for 
the gut microbiota diversity – by the FinnBrain research group. The analysis focused on 
alpha, beta diversities and the differential abundance of the intestinal microbiota. This 
exploratory research shows the absence of associations between the gut microbiota and the 
brain striatum volumes.  
4.1 Participants’ characteristics and main variables 
The mean gestational age was 39.9 weeks. Most of the babies were born vaginally 
(80%). Mode of delivery data was missing for two individuals (1 boy and one girl). The 
majority of the infants were exclusively breastfed at the time of the fecal sample (77%). Only 
two boys were not breastfed at all. Also, there were no significant sex differences in 
breastfeeding patterns (p = 0.53) or birth mode (p = 0.90). There were no important variations 
in ages at fecal sampling (mean = 68 days) and at scan (mean = 25 days from conception) 
between boys and girls. (Table 2). The average difference between scan and fecal sampling is 














Table 2. Study participants’ clinical characteristics as mean (standard deviation, SD) or count 
(percentage, %). Gestational weeks = gwk, not available = NA.  
Mean/Count (SD/%)  Overall Boys Girls 
  n = 56 n = 24 n = 32 
     
Gestational age, weeks  39.96 (1.16) 39.77 (1.15) 40.10 (1.16) 
     
Gestational stage  Pre-term < 37 gwk 
Full term < 40 gwk 
Late term < 42 gwk 













     












     
Delivery mode, n  Vaginal 











     
Feeding mode, n  Exclusive breastfeeding 
Partial breastfeeding 
Cessation before 2.5 months age  













     
Age at fecal sampling, 
days  
 68 (14) 69 (15) 67 (14) 
     
Age at scanning, days 
(from birth) 
 25 (7) 25 (8) 24 (5) 
 
Mean volumes are for the caudate nuclei 1405.32 and putamina 1462.88. There is no 
difference in the right hemisphere caudate nucleus and putamen and left hemispheres 
structures volumes. Boys have higher striatum volumes overall than girls, however these 
results did not differ with statistical significance (t= 0.88, p = 0.38). Alpha diversity (Shannon 
Index, i.e., relative microbial abundance) of the infant's gut microbiota was higher in girls 




Table 3. Main variables as means (standard deviation, SD) 
Mean (SD)  Overall Boys Girls 
  n = 56 n = 24 n = 32 




Left Caudate Nucleus  
 
Right Caudate Nucleus 
 



























     
Alpha diversity 
(Shannon Index) 
 1.62 (0.52) 1.51 (0.48) 1.71 (0.55) 
4.2 No association between alpha diversity and striatum volumes 
Associations between gut microbiota alpha-diversity and striatum volumes were 
visually investigated on scatter plots with linear regression lines (Figure 2). Figure 2 displays 
the relationship between alpha diversity and striatum volumes separately for left and right 




Figure 2. Scatter plots of brain volumes for A) left-caudate nucleus, B) right-caudate nucleus, C) left-
putamen, D) right-putamen in function of the alpha-diversity of the gut microbiota. The slope of the 
blue regression line in each plot has been calculated by a linear regression model. Each point in the 
scatter plots represent an infant from the sample. Statistics performed by Spearman’s r correlation test 
(A, r = 0.03, p = 0.75 / B, r = -0.04, p = 0.44/ C, r = 0.02, p = 0.68 / D, r = 0.01, p = 0.71).  
 
Alpha diversity (mean Shannon Index = 1.62, SD = 0.52) did not correlate with any of 
the striatum volumes (left caudate nucleus (LC), right caudate nucleus (RC), left putamen 
(LP) and right putamen (RP)) in the unadjusted analyses (Spearman’s correlation r for LC, r = 
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0.03, p = 0.75; RC, r = -0.04, p = 0.44; LP, r = 0.02, p = 0.68 and RP, r = 0.01, p = 0.71). 
When adjusted for mode of delivery, feeding mode, gestational age at birth, child sex, birth 
weight, age at fecal sample, age at scan and antibiotics treatment, no correlation was found 
with alpha diversity (LC, p = 0.75, R2 = 0.09; RC, p = 0.44, R2 =0.09; LP, p = 0.68, R2 = 0.12 
and RP, p = 0.71, R2 = 0.11) (Table 4).  
Table 4. Correlations between alpha diversity and striatum volumes, after controlling for covariates 
birth mode, feeding mode, gestational age at birth, sex, birth weight, age at fecal sample and age at 
the scan.  
Striatum 
Volumes 
R coef. p-value R2 

















4.2.1 Sex differences in alpha diversity associations with caudate nuclei and 
putamina 
A stratified analysis for sex showed a slight difference in correlation between the 
alpha diversity and the striatum volumes, albeit not significant. Girls had a higher association 
between alpha diversity and the four striatal volumes (LC, r = 0.78, p = 0.44; RC, r = 0.77, p 
= 0.45; LP, r = 0.54, p = 0.60; RP, r = 0.53, p = 0.60) than boys (LC, r = 0.04, p = 0.97; RC, r 
= 0.65, p = 0.53; LP, r = -0.37, p = 0.72; RP, r = -0.08, p = 0.94). Also, the correlation 
evolved in opposite direction for both sex (Figure 3). However, after inclusion of an 
interaction term (diversity*sex) in the correlation analysis, the effect size revealed to be 
unsignificant, validating the previous results obtained during stratified analysis. Thus, no sex 




Figure 3. Scatter plots of brain volumes for A) left-caudate nucleus, B) right-caudate nucleus, C) left-
putamen, D) right-putamen in function of the alpha-diversity of the gut microbiota with regards to sex. 
The slope of the regression lines in each plot has been calculated by a linear regression model. Each 
point in the scatter plots represent an infant from the sample. Statistics performed by Spearman’s r 
correlation test for girls (LC, r = 0.78, p = 0.44; RC, r = 0.77, p = 0.45; LP, r = 0.54, p = 0.60; RP, r = 
0.53, p = 0.60) and boys (LC, r = 0.04, p = 0.97; RC, r = 0.65, p = 0.53; LP, r = -0.37, p = 0.72; RP, r = 
-0.08, p = 0.94).  
 
4.3 Absence of significant effect size for the beta diversity, despite similar 
beta distribution for covariates birth mode and sex.  
Gut microbiota beta diversity was first examined visually with PCoA scatter plots 
(Figure 4). Figure 4 shows the relationships between beta diversity and striatum volumes 




Figure 4. PCoA scatter plots for A) left-caudate nucleus, B) right-caudate nucleus, C) left-putamen, D) 
right-putamen, in the axis 1 and axis 2. The PCoA plots were obtained with the plot_ordination 
function of the phyloseq R package. Each point in the scatter plots represent an infant from the 
sample. Statistics performed by permanova test (A, R2 = 0.01, p = 0.94 / B, R2= 0.01, p = 0.57 / C, R2 
= 0.01, p = 0.61 / D, R2 = 0.02, p = 0.35).  
 
Beta diversities were insignificant for any of the striatum volumes (left caudate 
nucleus, right caudate nucleus, left putamen and right putamen) in the unadjusted analyses 
(LC, R2 = 0.01, p = 0.90; RC, R2 = 0.01, p = 0.82; LP, R2 = 0.01, p = 0.87; RP, R2 = 0.02, p = 
0.51) (Table 5). When adjusted for birth mode, feeding mode, gestational age at birth, sex, 
birth weight, age at fecal sample, age at scan and antibiotics treatment, beta diversities were 
unsignificant with the striatum structure (LC, R2 = 0.01, p = 0.93; RC, R2 = -0.01, p = 0.57; 
LP, R2 = 0.01, p = 0.61; RP, R2 = 0.02, p = 0.35). However, small significance was found for 
beta diversity with the following covariate variables: child sex (p <0.05) (Figure 5) and birth 
mode (<0.1) (Figure 6). Additionally, the beta dispersion, testing the similarity of variance in 
the composition among each individual, for all the covariate variables have been evaluated 







Table 5. Correlations between beta diversity and striatum volumes after controlling for covariates birth 
mode, feeding mode, gestational age at birth, sex, birth weight, age at the fecal sample, and age at 
the scan. Significance of <0.05 and <0.1 for covariates sex and birth mode respectively for all striatum 
volumes.  
Striatum Volumes p-value R2 















Figure 5. PCoA scatter plots for sex of the child ((F = 0.58, p = 0.45) in axis 1 and 2. The PCoA plots 
were obtained with the plot_ordination function of the phyloseq R package. Each point in the scatter 




Figure 6. PCoA scatter plots for birth mode (F = 1.37, p = 0.25) in axis 1 and 2. The PCoA plots were 
obtained with the plot_ordination function of the phyloseq R package. Each point in the scatter plots 
represents an infant from the sample. 
 
Table 6. Beta dispersion for covariates variables birth mode, feeding mode, gestational age at birth, 
sex, birth weight, age at the fecal sample, and age at the scan. *** p-value <0.  
Striatum Volumes F-value p-value 





Age at fecal sample 















4.4 Absence of significant differential abundance at genus level in the 
sampled microbiota 
Differential abundance of the microbiota at genus level was not correlated with any of 
the striatum volumes (left caudate nucleus, right caudate nucleus, left putamen and right 
putamen), when adjusted for birth mode, feeding mode, gestational age at birth, sex, birth 
weight, age at fecal sample, and age at scan (LC, mean = -0.04, p = 0.76; RC, mean = -0.13, p 





Although gut-brain axis influence in neurodevelopment processes has been exposed in 
preclinical and clinical studies, we currently have a limited understanding of the initial 
interplay between gut microbiota and brain maturation during early life. In this study – 
explorative in nature – the aim was to shed light on the origins of the relationship between the 
infant gut microbiota diversity and deep brain structure evolution as previous literature is 
scarce. Despite modest effect size, an association between gut microbiota diversity, caudate 
nuclei, and putamina volumes was expected. Indeed, previous findings from Carlson et al. 
(2018) indicated a link between alpha diversity and various brain regions' volumes at two 
years of age. Previous literature also demonstrated associations with other structures such as 
the amygdala (Gao et al., 2019). Discordant with our hypothesis, our results did not attest of a 
significant association between the selected gut microbiota measures, intra-individual 
diversity and differences in overall composition, and the striatum volumes during infancy.  
5.1 Absence of correlation between the gut microbiota characteristics and 
striatum volumes 
As advanced in previous studies, gut microbiota may play a critical role in brain 
development in early infancy. Indeed, previous studies demonstrated that both the microbiota 
and brain critical but sensitive developmental windows were temporally coordinated (Borre et 
al., 2014). Furthermore, brain development is very vulnerable to internal and external 
environmental factors, such as gut microbiota and maternal prenatal health (Borre et al., 2014; 
Jena et al., 2020). Hence, developing our understanding of the co-development and 
bidirectional communication of gut and brain would allow early life interventions when gut 
microbiota modulation is possible (Christian, 2019). However, clinical microbiota-gut-brain 
axis studies on the infant population are heavily lacking. To date, only one study by Carlson 
et al. (2018) that directly evaluated the microbiota-gut-brain interplay focusing on the early 
brain and cognitive development in infants. They suggest that microbial diversity may affect 
cognitive function in early life and showed that cognitive development at two years of age 
could be predicted from the microbial diversity at one year of age. Additionally, they reported 
structural brain differences by which alpha diversity showed an association with several 
regional gray matter volumes. However, they showed no association at neither one nor two 
years of age between alpha diversity and the caudate nuclei.  
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Contrary to our hypothesis, the presented results did not evince the presence of a 
relationship between infant gut microbiota diversity and the caudate nuclei and putamina. 
Diversity is a standard measure used to characterize the microbiota, and the alpha diversity 
assesses the mean bacteria species diversity within a sample and is expressed through indices 
(Hagerty et al., 2020, Kelsey et al., 2019). This study used the Shannon index of alpha 
diversity in our statistical analysis, and internal and external influences on the gut microbiota 
and/or the infant's brain were taken into account as confounding variables for all statistical 
testing. The gut microbiota alpha diversity was tested for association with left and right 
hemispheres caudate nucleus and putamen using a Spearman's correlation, resulting in an 
insignificant and low correlation coefficient. These results are consistent with the findings of 
Carlson et al. (2018). Besides, exploring sex differences in the association between alpha 
diversity and striatum volumes was insignificant, despite visually demonstrating a stronger 
association in girls. Furthermore, the calculation of the beta dispersion (compositional 
heterogeneity in microbiota by measuring variance of the distance to the group centre) and 
beta diversity (compositional similarity of microbiota) for the population were performed but 
did not demonstrate any significant effect size when tested caudate nuclei and putamina. Also, 
the differential abundance showed an absence of significant microbial signature within our 
sample regarding the left and right caudate nucleus and putamen.  
The paucity of studies conducted on infants limits our ability to validate and interpret 
our results against previous findings. A considerable number of past gut-brain axis studies 
focused their attention on crucial cerebral components involved in various early cognitive 
developmental processes (e.g., attention, emotion, or temperament) or neurodevelopmental 
disorders (e.g., ADHD or autism). For instance, the amygdala, a crucial subcortical structure 
for emotional and cognitive processing (e.g., fear), has been reported to be associated (i.e., 
volume and functional connectivity) with infant gut microbiota diversity (Carlson et al., 2018; 
Gao et al., 2019). The amygdala volume and functional connectivity appeared to be associated 
with alpha diversity (Carlson et al., 2018; Gao et al., 2019) negatively. Moreover, findings by 
Christian et al. (2015) attest of a correlation between the gut microbiota beta diversity and 
fear reactivity, a response involving the amygdala. Together, these results show the gut 
microbiota may be associated with specific subcortical structures. Hence, we hypothesized 
that the amygdala results could be extrapolated to other subcortical structures, such as the 




Arguably, the absence of a significant association between microbiota diversity and striatum 
volumes might be explained by the temporal variation in microbial diversity and the PNI 
pathways development (Jena et al., 2020; Stewart et al., 2018). The population-level analysis 
of gut microbiome variation by Falony et al. (2016) yields indication of incomplete total gut 
diversity in infancy. This may be due to the fact that microbiota diversifies through the first 
year of life, especially at dramatic periods of change in diet such as weaning and the 
introduction of solid foods (Stewart et al., 2018). Nevertheless, the role of early microbiota 
diversity on later health remains to be elucidated. Presumably, a more diverse microbial 
community usually concords with better health in adults (Menni et al., 2017; Hooks et al., 
2018; Shade et al., 2017); thus, the same could be inferred for infants. 
Additionally, the gut-brain communication pathways are still in their infancy during 
early life. For instance, the vagus nerve, critical in gut-brain neural communication, is still not 
fully myelinated in early infancy. Additionally, the immune defence for the body during 
infancy is provided through the mother's milk high in level of immune mediators. Indeed, the 
relatively immature immune system in the first months, or years of life, develops via 
stimulation by the gut microbiota community. Hence, the immune and neural pathways 
critical for gut-brain communication are not fully developed and functional in early life. This 
lack of development might reduce the influence of the gut microbiota on brain structural and 
functional development. Or rather, it could be hypothesized that the influences of the gut 
microbiota, or other early life environment exposures, are only visible later in infancy of 
childhood.  
The microbiota, in addition to temporal variation, also has spatial and potential sexual 
variability. The intestinal microbiota composition varies along the gastrointestinal tract's 
length, with the highest diversity in the colon (Tropini et al., 2017; Jena et al., 2020; Sekirov 
et al., 2010). Fecal sampling provides us with information regarding the microbial community 
present in the colon's lumen, which is more abundant than the mucosal microbiota (Ringel et 
al., 2015; Tropini et al., 2017). Further gut-brain research should implement a combinatory 
sampling from the luminal and microbiota to show the entire spectrum of microorganisms 
living in our gut. However, sampling mucosal microbiota requires an intestinal wall biopsy, 
an invasive procedure that is impractical for infant population studies. Sex variability is 
another factor that has been suggested to affect the gut-brain axis. For instance, gender-
specificity has been shown in neurochemical and endocrine effects of gut microbiota, anxiety 
behaviour or social development (Cryan & O'Mahony, 2011; Neufeld et al., 2011; Desbonnet 
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et al., 2014). Besides, a study by Acosta et al. (2020) observed sex-specificity for caudate 
volumes association with the genetical risk for major depressive disorder. The study 
demonstrated a stronger positive association in boys than girls. However, we visually 
observed a small sex-dependent difference in the microbiota-striatum volumes associations, 
yet not significant. This lack of significance of sex-specificity in the association between gut-
microbiota and striatum volumes appears to be at odds with previous literature suggesting sex 
variability. However, it could be a reflection of the low statistical power of the current study 
leading to the impossibility of detecting such a small to moderate effect. In all, further gut-
brain studies focusing on gender-specificity are necessary to determine the translatability of 
preclinical results in humans.  
5.2 Limitations 
Particular limitations in this exploratory study needs to be acknowledged. The following are 
developed: statistical power, confounding factors, temporality and single time point 
assessment, and gut microbiota metrics.  
5.2.1 Statistical power  
This study consisted of a sample of 56 infants. Several factors directly influenced the 
infant's gut microbiota and brain volume variability and were considered as covariate 
variables. However, the statistical power may have been inadequate in detecting a small effect 
even if one was present, as it would have been limited. A post hoc investigation of the 
statistical power of our study demonstrated that in order to detect the potent effect of gut 
microbiota of the striatum with a power of 80%, we would need a population size of at least 
twice the current size (~120) for a medium effect or even twelve times higher (~700) for a 
small effect. Indeed, as the population size increases, the effect size that can be detected 
becomes smaller. Moreover, a statistical power of 80% was advanced as the desired power in 
research by Cohen (1992), but due to the paucity of literature on the subject, and with this 
specific design in this age group, the population size needed for sufficient statistical power 
could not be determined before the study. Additionally, the population size was limited for 
practical reasons, as only 56 infants provided a fecal sample from the ~200 infants who 
underwent the MRI scanning. Therefore, this study only had enough statistical power to 
detect large effects, so forthcoming studies must favor larger sample size, when possible, to 
optimize statistical power in order to observe a small to moderate effect size. 
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5.2.2 Confounding factors  
The microbiota composition is significantly influenced by breastfeeding and delivery 
mode (Stewart et al., 2018; Borre et al., 2014), as a TEDDY study showed associations 
between breastfeeding and high levels of Bifidobacterium species as well as vaginal birth and 
high levels of Bacteroidetes (Stewart et al., 2018). Indeed, vaginal and cesarian deliveries 
expose the infant to the different microbial milieu, correlating with gut microbiota diversity 
(Stewart et al., 2018) and later developmental outcomes (Borre et al., 2014). Infant delivered 
by the cesarian section shows a higher risk to suffer from allergies, gastrointestinal 
dysfunction or diabetes later in life (Jakobsson et al., 2014; Domingez-Bello et al., 2010). In 
addition to delivery mode, genetic and environmental factors also help define the microbiome. 
The microbiome has been suggested to cluster within families but with significant 
contribution from environmental factors over genetics (Lozupone et al., 2012; Maynard et al., 
2012). Similar to birth mode, infants born prematurely lack two of the major bacterial genera 
seen in infants born at term, although they were acquired through breastfeeding (Barrett et al., 
2013). Also, studies showed stabilization in the microbiota composition through 
breastfeeding, contrary to formula feeding, which leads to higher diversity (Fan et al., 2014, 
Roger et al., 2010). Besides, breastfeeding cessation is a determinant for adult-like microbiota 
maturation in late infancy (Bäckhed et al., 2015). Therefore, in this study, covariate variables 
included infant sex, birth mode and feeding mode at fecal sample. Diversity, precisely beta 
diversity, exhibited a correlation with birth mode and child sex, but not with feeding mode. 
However, the majority of the infant population were vaginally delivered (80%) and breastfeed 
(77%), so the sample was relatively homogenous and could not represent all the possible 
delivery and feeding status (e.g., cesarian or formula feeding) evenly. Other factors, including 
siblings and antibiotic treatments, could have been considered, as they have been suggested to 
associate with microbiome profiles and maturation (Stewart et al., 2018; Bokulich et al., 
2016). Yet, these studies are focusing on children, not infants, so it is conceivable that these 
factors (i.e., sibling and antibiotics) may play a more important role in later microbiota 
composition as the number of antibiotic treatments in the first few months of life is generally 
lower than during toddlerhood or childhood. Additionally, siblings and antibiotic treatments 
are associated with the gut microbiota and might not influence striatum volumes.  
In addition to confounding factors influencing gut microbiota, brain volumes (e.g., 
striatum or amygdala) might be influenced by internal and external factors, including maternal 
health, medication exposure and genetics. Studies showed the influence of genetic variation 
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and environmental and epigenetic factors on amygdala volumes (Ong et al., 2019; Satizabal et 
al., 2019). Hence, infant medications (e.g., antibiotics) and maternal medication (e.g., anti-
depressants) could have been taken into account, as it could be hypothesized that they may 
influence striatal volumes similarly to amygdala volumes (Aatsinki et al., 2020). However, 
the influence of genetic variation on early microbiota association with brain structural and 
functional development should be explored with further research.  
5.2.3 Single time point assessment and temporality 
The age group of the population is more challenging when measuring gut microbiota 
properties, such as diversity, as infants undergo swift gut microbiota colonization and 
maturation all along the first years of life until the age of 3 years (Jena et al., 2020; Stewart et 
al., 2018; Borre et al., 2014). Indeed, the microbiota flourishes into an intricate, adult-like 
composition characterized by higher alpha diversity and lower beta diversity (Bäckhed et al., 
2015; Yatsunenko et al., 2012). Similarly, brain development is vital during the first years of 
life, with significant cognitive, emotional and structural changes (Borre et al., 2014; Carlson 
et al., 2018; Gilmore et al., 2012; Knickmeyer et al., 2008; Provost, Hanganu, and Monchi, 
2015). Hence, together with the considerable changes in fecal microbial composition and 
diversity at weaning and the introduction of solid food (Borre et al., 2014), the presumed 
connection between gut microbiota and the brain may only develop later during infancy, i.e., 
post weaning. Or rather, it could be also developed that the gut-brain connections may 
represent differently in later timepoints of early life (e.g., toddlerhood), than during infancy. 
Therefore, to fully understand the gut-brain associations over the course of early life, from 
birth to the end of childhood, multi-time point assessments study design should be considered 
in future research. 
Several limitations in our study arise from the rapid evolution of the intestinal 
microbiota and brain. First, both the gut microbiota and striatum volumes were assessed by a 
single time point sample at respectively 2.5 months and one month approximatively. 
Secondly, the temporal distance of approximately five weeks between the MRI measurements 
and fecal sample might be a great source of variability, especially regarding the gut 
microbiota. Indeed, as mentioned previously, the microbiota has a rapid evolution, and the 
important temporal difference between the two samples may be a source of inaccuracy in the 
gut microbiota characteristics. Furthermore, fecal sampling was done after the infant's MRI 
imaging, so the infant gut microbiota at 2.5 months of age might be reasonably different – 
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more developed – than at one month of age when undergoing imaging. This temporal 
difference highlights the dual impact of time on the information extracted from the gut 
microbiota composition and the brain imaging and the resulting observation of associations. 
Hence, it should be noted that our results only describe a snapshot of the possible associations 
during infancy, so further studies are needed. Importantly, studies with longitudinal designs 
will provide a more substantial report concerning the parallel gut microbiota and brain 
development and interactions in early life. 
5.2.4 Gut microbiota diversity indexes 
This thesis implemented a narrowed view of the gut microbiota, as diversity 
parameters might be over-simplistic to characterize fecal microbiota. Indeed, a study by 
Shade (2017) points out that microbial diversity calculations possess biases and thus should 
be used as rough approximations as they are not absolute values. In this study, we solely used 
the Shannon index as a representation of alpha diversity. Previous studies often use four 
different indices to assess alpha diversity, including observed species, Faith's Phylogenic 
Diversity, and Chao1 (Gao et al., 2019; Carlson et al., 2018). Together, they provide 
information about taxonomic and phylogenic composition, richness, and evenness in the 
sample (Navas-Molina, 2013; Gao et al., 2019). In this study, the Shannon index of alpha 
diversity provides information on the fecal microbiota community's richness and evenness. 
Therefore, future studies should implement a combination of alpha diversity indices to get a 
more global picture of the associations between microbiota diversity and brain structures. 
Moreover, the diversity and abundance measures performed in this study fail to appreciate the 
functional properties of gut microbiota, which may be crucial in gut-brain communication. 
Consequently, a complementary assessment of gut microbiota structure and functionality via a 
two-stage experiment combining 16S rRNA sequencing and shotgun sequencing (description 
of the functional potential of microbiota) would provide information about both the gut 
microbiota structure and its metabolites' influences on brain neurodevelopment (Morgan & 
Huttenhower, 2014; Tickle et al., 2013).  
5.3 Future research 
Future studies are critical in enriching the limited literature concerning infant gut-brain 
axis. Exploration of whether and how the gut microbiota composition, diversity and 
functionality correlate with the brain structural, cognitive and behavioural development in 
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infant would elevate the current understanding of the origins of the gut-brain axis. Besides, 
reporting null or negative results in published literature would permit development of interest 
amongst researchers as well as improvement of study designs to confirm or infirm the absence 
of correlations between gut microbiota and brain development in infancy. Furthermore, future 
study designs should draw methodological improvements from the conclusions and 
limitations of our novel study. As such, a longitudinal design of a large infants’ cohort with 
consideration of broader confounding factors and diversity indexes and both structural and 
functional aspects of neurodevelopment, may provide sufficient statistical power and 
temporality to observe a significant correlation (small or moderate) between the gut 
microbiota and the brain. In all, future insight in gut-brain relationship during infancy will add 





This thesis explored the potential association between striatum volumes and gut 
microbiota diversity. The present findings only present a snapshot of the gut-brain relation in 
infancy. Despite the lack of clear associations, this thesis added to the currently limited 
literature investigating the origins of the microbiota-gut-brain axis communication. 
Importantly, further studies exploring neonatal gut microbiota and its associations with brain 
structural and functional development would provide essential information on the parallel gut 
and brain development interplay. Overall integrity in brain structure and function is vital for 
our well-being throughout life, so it is important to understand how external factors, such as 
gut microbiota, influences early life neurodevelopment. Further studies are important to 
examine how the gut microbiota composition, diversity and functionality associate with brain 
structures or processes. Additionally, longitudinal research is needed to provide insight into 
how gut microbiota associates with the brain during the critical period of neurodevelopment 
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